Bladder Cancer - Results from #180

Fluid intake and recurrence and progression risk of patients with non-muscle-invasive bladder cancer. January 28, 2025

Metformin intake and risk of metabolic acidosis after radical cystectomy with urinary diversion: A comparative study using data from the TriNetX research network. January 27, 2025

Association of Prehabilitation in the Precystectomy Pathway in Patients With Bladder Cancer on Postoperative Outcomes. January 27, 2025

Ethnicity and race as modifiers of the association between patient sex and stage at diagnosis of bladder cancer. January 24, 2025

Xpert Bladder Cancer Detection in Emergency Setting Assessment (XESA Project): A Prospective, Single-centre Trial. January 24, 2025

A New AI Model for Grading Non-Muscle Invasive Bladder Cancer - Expert Commentary January 23, 2025

Impact of race-based calculations of eGFR on the management of muscle invasive bladder cancer. January 23, 2025

AI predicting recurrence in non-muscle-invasive bladder cancer: systematic review with study strengths and weaknesses. January 23, 2025

Precise grading of non-muscle invasive bladder cancer with multi-scale pyramidal CNN. January 23, 2025

Is pT0 a Reliable End Point for Biomarker Discovery for Preoperative Chemotherapy Response in Patients with Bladder Cancer? January 22, 2025

A multicenter study of perioperative and functional outcomes of open vs. robot assisted uretero-enteric reimplantation after radical cystectomy. January 22, 2025

En bloc resection of large bladder tumor: is it feasible and reasonable? January 22, 2025

Intravesical Administration of Durvalumab for High-risk Non-muscle-invasive Bladder Cancer: A Phase 2 Study by the Hellenic GU Cancer Group. January 22, 2025

Outcomes after Radical Cystectomy in Patients with Primary Versus Secondary Bladder Cancer - Expert Commentary January 21, 2025

Spatial distribution and subtype-specific expression patterns of Nectin-4 in muscle-invasive bladder cancer. January 21, 2025

Is there a role for neoadjuvant therapies followed by radical cystectomy in oligometastatic bladder cancer? January 21, 2025

Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer. January 20, 2025

Comprehensive Genetic Profile of Chinese Muscle-Invasive Bladder Cancer Cohort. January 20, 2025

Immunohistochemistry-based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy. January 17, 2025

Validation of clinical T stages and of prognostic negative markers in patients with muscle invasive bladder cancer: data in the Swedish National Bladder Cancer Registry vs. data from a detailed research database. January 17, 2025

Page 10 of 535